(Q44426709)

2 December 2017

Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status (English)

1 reference

2 December 2017

1 reference

1 reference

Nehama Linder

1

1 reference

2 December 2017

Esther Tallen-Gozani

2

1 reference

2 December 2017

Boris German

3

1 reference

2 December 2017

Poriya Duvdevani

4

1 reference

2 December 2017

Asaf Ferber

5

1 reference

2 December 2017

Lea Sirota

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

2 December 2017

1 reference

2 December 2017

22

1 reference

2 December 2017

1509-1514

1 reference

2 December 2017

11-12

1 reference

Jamaica's measles elimination experience

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Eradication of vaccine-preventable diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Measles Eradication in the Americas: Experience in Haiti

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Progress in Accelerated Measles Control in the People’s Republic of China, 1991–2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Child vaccination policies in Europe: a report from the Summits of Independent European Vaccination Experts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Measles in Europe in 2001-2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Current status of measles in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Measles in France: the epidemiological impact of suboptimal immunisation coverage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Measles virus specific antibody in infants in a highly vaccinated society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Maternal immunity to measles and infant immunity at less than twelve months of age relative to maternal place of birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Serum Immunoglobulin Levels in Premature and Full-term Infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Serum-gamma-G-globulin levels in normal premature, post-mature, and "small-for-dates" newborn babies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Serum gamma-G-globulin levels and gestational age in premature babies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Role of virus strain in conventional and enhanced measles plaque neutralization test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Measles antibody titers in early infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Increased susceptibility to measles in infants in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Antibody against viruses in maternal and cord sera: specific antibody is concentrated on the fetal side of the circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Maternally derived measles immunity in era of vaccine-protected mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

The influence of prematurity and low birthweight on transplacental antibody transfer in a rural West African population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Measles, mumps, and rubella serology in premature infants weighing less than 1,000 grams

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Measles antibodies in women and infants in the vaccine era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Transplacental transfer of measles and total IgG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Early immunization with inactivated poliovirus vaccine in premature infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Immunogenicity of hepatitis B vaccine in preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Effect of maternal immunization with oral poliovirus vaccine on neonatal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Boosting effect of a second dose of measles vaccine given to 12-year-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.009

10.1016/J.VACCINE.2003.10.009

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference